REVELABIOME Trademark

Trademark Overview


On Tuesday, April 6, 2021, a trademark application was filed for REVELABIOME with the United States Patent and Trademark Office. The USPTO has given the REVELABIOME trademark a serial number of 79320397. The federal status of this trademark filing is REGISTERED as of Tuesday, July 5, 2022. This trademark is owned by Gnubiotics Sciences SA. The REVELABIOME trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Animal and human microbiome sample collection kits, consisting of a tube for collection of saliva, blood and fecal matter, as well as caps for tubes; devices, apparatus and equipment for medical use for diagnostic analysis of animal and human microbiome; next-generation sequencing (NGS) medical devices, apparatus and equipment, used for animal and human microbiome analysis; next-generation sequencing (NGS) medical instruments for animal and human microbiome analysis

Provision of Internet platforms (PaaS) featuring software for animal and human microbiome data analysis for next-generation sequencing (NGS); scientific genetic data analysis, sequencing and solution sampling services
revelabiome

General Information


Serial Number79320397
Word MarkREVELABIOME
Filing DateTuesday, April 6, 2021
Status700 - REGISTERED
Status DateTuesday, July 5, 2022
Registration Number6776976
Registration DateTuesday, July 5, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 18, 2022

Trademark Statements


Goods and ServicesAnimal and human microbiome sample collection kits, consisting of a tube for collection of saliva, blood and fecal matter, as well as caps for tubes; devices, apparatus and equipment for medical use for diagnostic analysis of animal and human microbiome; next-generation sequencing (NGS) medical devices, apparatus and equipment, used for animal and human microbiome analysis; next-generation sequencing (NGS) medical instruments for animal and human microbiome analysis
Goods and ServicesProvision of Internet platforms (PaaS) featuring software for animal and human microbiome data analysis for next-generation sequencing (NGS); scientific genetic data analysis, sequencing and solution sampling services

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGnubiotics Sciences SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameGnubiotics Sciences SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameGnubiotics Sciences SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, October 18, 2021ASSIGNED TO EXAMINER
Monday, December 13, 2021REFUSAL PROCESSED BY IB
Thursday, September 16, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 28, 2021APPLICATION FILING RECEIPT MAILED
Monday, October 25, 2021NON-FINAL ACTION WRITTEN
Tuesday, October 26, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 23, 2021REFUSAL PROCESSED BY MPU
Tuesday, November 23, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 18, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 29, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 29, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, January 15, 2022NOTIFICATION PROCESSED BY IB
Tuesday, January 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, May 29, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, July 5, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, June 22, 2024NEW REPRESENTATIVE AT IB RECEIVED
Sunday, June 9, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 5, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 5, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 15, 2022FINAL DISPOSITION PROCESSED
Saturday, October 15, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 7, 2022FINAL DECISION TRANSACTION PROCESSED BY IB